Equities

MED SA

MED:ATH

MED SA

Actions
  • Price (EUR)0.945
  • Today's Change0.035 / 3.85%
  • Shares traded75.50k
  • 1 Year change-1.56%
  • Beta--
Data delayed at least 20 minutes, as of Nov 15 2024 14:44 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1.250.371.27
Total Receivables, Net1.581.010.29
Total Inventory3.622.912.09
Prepaid expenses------
Other current assets, total----0
Total current assets6.454.293.65
Property, plant & equipment, net4.284.326.32
Goodwill, net------
Intangibles, net0.110.110.00
Long term investments------
Note receivable - long term0.230.250.22
Other long term assets00--
Total assets119.0910
LIABILITIES
Accounts payable1.301.010.90
Accrued expenses------
Notes payable/short-term debt0.500.200.01
Current portion long-term debt/capital leases0.670.670.76
Other current liabilities, total0.030.030.05
Total current liabilities2.511.921.72
Total long term debt3.842.813.55
Total debt5.023.684.32
Deferred income tax--00.15
Minority interest1.911.971.93
Other liabilities, total0.430.480.52
Total liabilities8.697.187.86
SHAREHOLDERS EQUITY
Common stock2.862.862.86
Additional paid-in capital0.320.320.32
Retained earnings (accumulated deficit)(0.07)0.731.15
Treasury stock - common(0.41)(2)(2)
Unrealized gain (loss)------
Other equity, total--00
Total equity2.711.912.33
Total liabilities & shareholders' equity119.0910
Total common shares outstanding121212
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.